3/6/2023 6:41:20 PM Bridging Valuation Gaps in Public M&A in the Pharma, Biotech, and Other Life Sciences Industries By Jenny Hochenberg Adam Golden Acquisitions of public companies in pharma, biotech, and other life sciences industries are increasingly using deal structures designed...
